The first case of pulmonary disease caused by Mycobacterium septicum in China

Int J Infect Dis. 2013 May;17(5):e352-4. doi: 10.1016/j.ijid.2012.12.011. Epub 2013 Jan 24.

Abstract

Mycobacterium septicum is a rapidly growing Mycobacterium (RGM) that rarely causes pulmonary disease globally. We describe a case of M. septicum pulmonary disease, which to our knowledge is the first reported in China. The isolates were identified as M. septicum and were susceptible in vitro to amikacin, ciprofloxacin, ofloxacin, levofloxacin, kanamycin, and sulfamethoxazole.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Diagnostic Errors
  • Drug Resistance, Multiple, Bacterial
  • Drug Therapy, Combination
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Mycobacterium / drug effects
  • Mycobacterium / genetics*
  • Mycobacterium Infections, Nontuberculous / diagnosis*
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Phylogeny
  • Pneumonia, Bacterial / diagnosis*
  • Pneumonia, Bacterial / drug therapy
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents